These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India. Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429 [TBL] [Abstract][Full Text] [Related]
27. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease. Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330 [TBL] [Abstract][Full Text] [Related]
28. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers. Dukart J; Sambataro F; Bertolino A J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease. Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215 [TBL] [Abstract][Full Text] [Related]
30. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. Cavedo E; Lista S; Khachaturian Z; Aisen P; Amouyel P; Herholz K; Jack CR; Sperling R; Cummings J; Blennow K; O'Bryant S; Frisoni GB; Khachaturian A; Kivipelto M; Klunk W; Broich K; Andrieu S; de Schotten MT; Mangin JF; Lammertsma AA; Johnson K; Teipel S; Drzezga A; Bokde A; Colliot O; Bakardjian H; Zetterberg H; Dubois B; Vellas B; Schneider LS; Hampel H J Prev Alzheimers Dis; 2014 Dec; 1(3):181-202. PubMed ID: 26478889 [TBL] [Abstract][Full Text] [Related]
31. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers. Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L; J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024 [TBL] [Abstract][Full Text] [Related]
32. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota. Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623 [TBL] [Abstract][Full Text] [Related]
33. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364 [TBL] [Abstract][Full Text] [Related]
35. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment. Xu L; Wu X; Chen K; Yao L Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855 [TBL] [Abstract][Full Text] [Related]
36. Potential Role of Neuroimaging Markers for Early Diagnosis of Dementia in Primary Care. Teipel S; Kilimann I; Thyrian JR; Kloppel S; Hoffmann W Curr Alzheimer Res; 2018; 15(1):18-27. PubMed ID: 28891447 [TBL] [Abstract][Full Text] [Related]
37. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766 [TBL] [Abstract][Full Text] [Related]
38. Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection. Risacher SL; Saykin AJ Annu Rev Clin Psychol; 2013; 9():621-48. PubMed ID: 23297785 [TBL] [Abstract][Full Text] [Related]
39. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease. Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW; J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335 [TBL] [Abstract][Full Text] [Related]
40. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers. Ota K; Oishi N; Ito K; Fukuyama H; ; J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]